Business, energy, technology, markets and global industry news from Business News Today

NRX-100

PharmaDeviceNews NRX-100
Pharma & Biotech

Why Kadima is suing NRx Pharmaceuticals over the failed HOPE Therapeutics acquisition

The legal fight over Kadima Neuropsychiatry Institute tests NRx Pharmaceuticals’ acquisition discipline, financing credibility and evolving interventional psychiatry strategy.

Read More
Representative image of an outpatient neurostimulation treatment session, reflecting HOPE Therapeutics’ use of Zeta Surgical’s FDA-cleared TMS navigation system and the growing role of AI-guided precision psychiatry in treatment-resistant depression care.
Pharma & Biotech

Why HOPE Therapeutics’ first Zeta-guided TMS patients matter for psychiatry care

NRx’s HOPE Therapeutics begins Zeta-guided TMS treatments, bringing AI-powered image guidance into outpatient depression care workflows.

Read More